Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

3.55
Delayed Data
As of Apr 29
 -0.24 / -6.33%
Today’s Change
1.50
Today|||52-Week Range
5.05
+15.64%
Year-to-Date

Today’s Trading

Previous close3.79
Today’s open3.74
Day’s range3.39 - 3.77
Volume2,489,736
Average volume (3 months)938,941
Market cap$359.1M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-21.43%
Earnings growth (this year)+18.63%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-37.48%
P/E ratioNM
Price/Sales67.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENTLEntellus Medical Inc-0.70-4.59%
ARAYAccuray Inc0.000.00%
AXGNAxoGen Inc+0.11+1.93%
CUTRCutera Inc-0.22-1.85%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$48.0M
Net profit margin-849.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs